Brief: BioArctic Says Sales Of Leqembi Reached EUR 200 Million In Eisai FY 2024
Feb 18 (Reuters) - BioArctic AB BIOAb.ST :
* LEQEMBI® SALES REACHES €200 MILLION - FIRST SALES
MILESTONE
ACHIEVED
* BIOARCTIC AB - MILESTONE WAS REACHED AS SALES OF LEQEMBI
REACHED
EUR 200 MILLION IN EISAI FISCAL YEAR 2024
Source text: ID:nPn3RRJHVa
Further company coverage: BIOAb.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioArctic AB
See all newsBrief: BioArctic And Lilly Sign Research, Collaboration Agreement
Brief: Bioarctic AB Declares Dividend Of Sek 2 Per Share With 1 June 2026 Record Date
Brief: Bioarctic Partner Eisai Presents Leqembi Sales Simulation
Sweden's BioArctic Q1 revenue drops sharply despite higher Leqembi royalties
Brief: BioArctic Q1 Operating Profit SEK 210.8 Million